Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406)

Fig. 3

Cumulative recurrence rate due to liver metastasis in stage III/IV gallbladder cancer patients without peritoneal dissemination or jaundice. Median time to recurrence for H0, H1, and H2 were 25.0, "not reached," and 7 months, respectively. H0, no liver metastasis; H1, one liver metastasis; H2, two or more liver metastasis; No at risk, number at risk

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us